Rapid Micro Biosystems, Inc.
NCM: RPIDLive Quote
📈 ZcoreAI Score
Our AI model analyzes Rapid Micro Biosystems, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get RPID Z-Score →About Rapid Micro Biosystems, Inc.
Healthcare
Medical Devices
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
📊 Fundamental Analysis
Rapid Micro Biosystems, Inc. demonstrates a profit margin of -140.3%, which is below the sector average, suggesting competitive pressure.
The company recently reported 37.3% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -86.8%, which indicates that capital utilization is currently under pressure.
At a current price of $2.12, RPID currently trades near the bottom of its 52-week range (4%), indicating potential value or weakness (Range: $2.00 - $4.94).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$97.03M
Trailing P/E
--
Forward P/E
-2.57
Beta (5Y)
1.60
52W High
$4.94
52W Low
$2.00
Avg Volume
258K
Day High
Day Low